Five advanced life science technology companies from SE Michigan will provide an 8 minute pitch outlining their products, their technology and their market opportunity. They will also detail recent accomplishments such as; FDA submissions, technical accomplishments, and manufacturing milestones, etc.
After each company has presented, we will have a question and answer session.
Participating companies include:
AlertWatch, Inc. produces clinical decision support systems for hospitals. Founded in 2011, AlertWatch simplifies patient monitoring with intuitive products for the OR or ICU. AlertWatch products now run at the University of Michigan and several other training hospitals across the United States.
Aquaro streamlines the histological sample preparation workflow. After many hours using a microtome during his graduate work in neuroscience, Aquaro’s founder grew frustrated by the manual process of sectioning and mounting experimental samples and decided there had to be a better, less tedious way. He invented the solution that Aquaro is marketing.
ENT Biotech Solutions
ENT Biotech Solutions, Inc. (ENT) has a novel, disposal device for removing adenoids/ tonsils that makes the surgery more economical and also less tedious for the surgeons, delivering quality care the patients.
Immaze is developing biosensing microfluidic assay devices that provide clinicians with information to navigate the complex maze of the immune response. Their goal is to personalize immune modulatory therapies to improve the health of individual patients.
ONL Therapeutics (ONL) is a biopharmaceutical company committed to protecting and improving the vision of patients with a range of retinal diseases and conditions. By advancing a novel breakthrough technology designed to protect photoreceptors against programmed cell death (apoptosis), ONL is pioneering an entirely new approach to preserving sight. It is the first and only company focused on preventing the death of photoreceptors – the root cause of vision loss and the leading cause of blindness.
RetroSense Therapeutics is developing gene therapy approaches to partial vision restoration in certain retinal conditions. These approaches were pioneered at Wayne State University, from which RetroSense has secured exclusive worldwide rights. The Company has recently received orphan drug designation from the U.S. FDA and has also won the prestigious Villalobos Award for innovation from the Angel Capital Association.
We hope you will join us for this exciting event highlighting the terrific work of companies based right here in SE Michigan.